Affiliation:
1. Department of Chemistry, College of Arts and Sciences, Washington State University, Pullman, WA 99164, USA
2. Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602, USA
Abstract
Since their first discovery in the 1960s by Alec Bangham, liposomes have been shown to be effective drug delivery systems for treating various cancers. Several liposome-based formulations received approval by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), with many others in clinical trials. Liposomes have several advantages, including improved pharmacokinetic properties of the encapsulated drug, reduced systemic toxicity, extended circulation time, and targeted disposition in tumor sites due to the enhanced permeability and retention (EPR) mechanism. However, it is worth noting that despite their efficacy in treating various cancers, liposomes still have some potential toxicity and lack specific targeting and disposition. This explains, in part, why their translation into the clinic has progressed only incrementally, which poses the need for more research to focus on addressing such translational limitations. This review summarizes the main properties of liposomes, their current status in cancer therapy, and their limitations and challenges to achieving maximal therapeutic efficacy.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference242 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015
2. Annual Report to the Nation on the Status of Cancer, 1975–2012, featuring the increasing incidence of liver cancer;Ryerson;Cancer,2016
3. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018
4. (2023, March 03). Cancer. Available online: https://www.who.int/news-room/fact-sheets/detail/cancer.
5. Cancer treatment and survivorship statistics, 2012;Siegel;CA Cancer J. Clin.,2012
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献